Ruffer’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.87M Buy
166,587
+97,161
+140% +$7.48M 0.35% 69
2026
Q2
$5.74M Buy
69,426
+9,235
+15% +$741K 0.2% 94
2026
Q1
$4.64M Buy
+60,191
New +$4.7M 0.19% 75

Other funds holding ANIP

Ruffer's ANIP Position: Q3 2026 in Review

Ruffer increased its ANI Pharmaceuticals (ANIP) stake by 140% in Q3 2026, buying an estimated $7.48M and bringing the position to 166,587 shares worth $6.87M. The position accounts for 0.35% of the portfolio, ranked #69.

Ruffer first reported a position in ANIP in Q1 2026 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Ruffer held 166,587 shares of ANI Pharmaceuticals worth $6.87M as of Q3 2026.
  • Ruffer bought 97,161 ANI Pharmaceuticals shares in Q3 2026, an estimated $7.48M.
  • ANI Pharmaceuticals made up 0.35% of Ruffer's portfolio in Q3 2026, its #69 holding.
  • Ruffer first reported a position in ANI Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.